scholarly article | Q13442814 |
P50 | author | Sarah L Braunstein | Q92894911 |
P2093 | author name string | Alan Neaigus | |
Kathleen H Reilly | |||
Suzan M Walters | |||
Lila Starbuck | |||
Valentina Ramirez | |||
Alexis V Rivera | |||
Bethany Coston | |||
P2860 | cites work | Syringe exchange as a social movement: a case study of harm reduction in Oakland, California | Q39467639 |
Social inequalities in adolescent human papillomavirus (HPV) vaccination: a test of fundamental cause theory | Q39481492 | ||
Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. | Q39567699 | ||
Dual HIV risk: receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City | Q40108921 | ||
Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs | Q40431814 | ||
Interpersonal Attacks on the Dignity of Members of HIV Key Populations: A Descriptive and Exploratory Study. | Q40502009 | ||
HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015. | Q40596722 | ||
HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report | Q40777604 | ||
Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs | Q41334205 | ||
People who inject drugs in prison: HIV prevalence, transmission and prevention | Q41458000 | ||
The effect of syringe exchange use on high-risk injection drug users: a cohort study | Q41732202 | ||
Respondent driven sampling--where we are and where should we be going? | Q42539598 | ||
Men who have sex with men and also inject drugs-profiles of risk related to the synergy of sex and drug injection behaviors | Q44029607 | ||
Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults | Q44109830 | ||
Sexual risk, substance use, and psychological distress in HIV-positive gay and bisexual men who also inject drugs | Q46394374 | ||
Stigma, discrimination and the health of illicit drug users | Q47585949 | ||
HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action | Q48594922 | ||
An Exploration of Factors Impacting Pre-exposure Prophylaxis Eligibility and Access among Syringe Exchange Users | Q49711144 | ||
Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC. | Q50860313 | ||
Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study. | Q51734189 | ||
Sexual identity distress, social support, and the health of gay, lesbian, and bisexual youth. | Q51913987 | ||
Heterosexual male and female disparities in HIV infection at the end of an epidemic: HIV infection among persons who inject drugs in New York City, 2001-2005 and 2011-2015. | Q52650934 | ||
Exchange Sex Among Persons Who Inject Drugs in the New York Metropolitan Area: The Importance of Local Context, Gender and Sexual Identity. | Q52691100 | ||
Racial/Ethnic Disparities at the End of an HIV Epidemic: Persons Who Inject Drugs in New York City, 2011-2015. | Q53730311 | ||
Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California | Q57282342 | ||
Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs | Q57473787 | ||
Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs | Q59340819 | ||
HIV infection among MSM who inject methamphetamine in 8 US cities | Q64136858 | ||
Impure science: AIDS, activism, and the politics of knowledge | Q74673654 | ||
Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999 | Q77697531 | ||
The importance of both sexual behavior and identity | Q83004727 | ||
Drug use, community action, and public health: gay men and crystal meth in NYC | Q84067979 | ||
[Sexually transmitted diseases: the impact of stigma and taboo on current medical care] | Q87430675 | ||
Sex, drugs and social connectedness: wellbeing among HIV-positive gay and bisexual men who use party-and-play drugs | Q88070812 | ||
Stimulant Use and Study Protocol Completion: Assessing the Ability of Men Who Have Sex with Men to Collect Dried Blood Spots for Laboratory Measurement of HIV Viral Load | Q90824733 | ||
PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland | Q91031784 | ||
An inverse relationship between perceived social support and substance use frequency in socially stigmatized populations | Q91787038 | ||
Factors Associated with Awareness of Pre-exposure Prophylaxis for HIV Among Persons Who Inject Drugs in Philadelphia: National HIV Behavioral Surveillance, 2015 | Q91864298 | ||
Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men | Q95824189 | ||
The trouble with "MSM" and "WSW": erasure of the sexual-minority person in public health discourse | Q24544876 | ||
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men | Q24612082 | ||
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women | Q28270788 | ||
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial | Q28292876 | ||
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis | Q28304793 | ||
A modified poisson regression approach to prospective studies with binary data | Q29615575 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
HIV incidence among injecting drug users in New York City syringe-exchange programmes | Q30233828 | ||
Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention | Q32174089 | ||
Correlates of Awareness of and Willingness to Use Pre-exposure Prophylaxis (PrEP) in Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Geosocial-Networking Smartphone Applications in New York City. | Q33447623 | ||
Knowledge of pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men in Denver, Colorado | Q33792136 | ||
Willingness to use HIV pre-exposure prophylaxis among opiate users | Q34021940 | ||
Knowledge and Attitudes about Pre-Exposure Prophylaxis (PrEP) among Sexually Active Men Who Have Sex with Men (MSM) Participating in New York City Gay Pride Events | Q34375870 | ||
A simulation study of the number of events per variable in logistic regression analysis | Q34411363 | ||
Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors | Q34511319 | ||
Psychosocial Implications of Homophobia and HIV Stigma in Social Support Networks: Insights for High-Impact HIV Prevention Among Black Men Who Have Sex With Men | Q34520612 | ||
Variance estimation, design effects, and sample size calculations for respondent-driven sampling | Q35230123 | ||
Evaluation of respondent-driven sampling. | Q35752128 | ||
Ideological Anachronism Involving Needle and Syringe Exchange Programs: Lessons From the Indiana HIV Outbreak | Q35832577 | ||
Comparison of Respondent Driven Sampling Estimators to Determine HIV Prevalence and Population Characteristics among Men Who Have Sex with Men in Moscow, Russia | Q36036227 | ||
Estimating design effect and calculating sample size for respondent-driven sampling studies of injection drug users in the United States | Q36056824 | ||
Beyond 'MSM': Sexual Desire Among Bisexually-Active Latino Men in New York City | Q36092337 | ||
Awareness of Post-Exposure Prophylaxis (PEP) and Pre-Exposure Prophylaxis (PrEP) Is Low but Interest Is High Among Men Engaging in Condomless Anal Sex With Men in Boston, Pittsburgh, and San Juan | Q36175090 | ||
The role of sexual transmission of HIV infection among injection and non-injection drug users | Q36273534 | ||
Intersectionality of internalized HIV stigma and internalized substance use stigma: Implications for depressive symptoms | Q36579887 | ||
Clear Links Between Starting Methamphetamine and Increasing Sexual Risk Behavior: A Cohort Study Among Men Who Have Sex With Men. | Q36678117 | ||
The importance of measuring and accounting for potential biases in respondent-driven samples | Q36906342 | ||
The role of formative research in the National HIV Behavioral Surveillance System | Q37015078 | ||
Prevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009 | Q37040594 | ||
Drug Addiction Stigma in the Context of Methadone Maintenance Therapy: An Investigation into Understudied Sources of Stigma | Q37094504 | ||
How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention | Q37526187 | ||
Social networks, sexual networks and HIV risk in men who have sex with men. | Q37620368 | ||
Differences in Awareness of Pre-exposure Prophylaxis and Post-exposure Prophylaxis Among Groups At-Risk for HIV in New York State: New York City and Long Island, NY, 2011-2013. | Q38730563 | ||
Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment. | Q38954055 | ||
P921 | main subject | sexual identity | Q1165905 |
needle exchange programme | Q1760326 | ||
P304 | page(s) | 102671 | |
P577 | publication date | 2020-02-21 | |
P1433 | published in | International Journal of Drug Policy | Q15759712 |
P1476 | title | The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs | |
P478 | volume | 77 |